Antibiotic susceptibility and prevalence of erythromycin ribosomal methylase gene, erm(B) in Streptococcus spp.

Veterinary Journal

Volumn 176, Issue 2, 2008, Pages 197-204

  Hung, Shao Wen ^a   Wang, Shu Ling ^a   Tu, Ching Yu ^a   Tsai, Yueh Chih ^a   Chuang, Shih Te ^a   Shieh, Meng Tong ^b   Liu, Pan Chen ^a   Wang, Way Shyan ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b FISHERIES RESEARCH INSTITUTE   (Taiwan)

Author keywords

Antibiotic susceptibility; erm(B) Gene; Erythromycin; Streptococcus spp.

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BACITRACIN; BACTERIAL PROTEIN; CLARITHROMYCIN; ENROFLOXACIN; ERYTHROMYCIN; ERYTHROMYCIN RIBOSOMAL METHYLASE PROTEIN; SPIRAMYCIN; UNCLASSIFIED DRUG;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; GENE AMPLIFICATION; GENE CLUSTER; GENE IDENTIFICATION; GENE SEGREGATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAMMAL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; STREPTOCOCCUS; TAIWAN;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; HUMANS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

ANIMALIA; MAMMALIA; STREPTOCOCCUS;

EID: 41049103431     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.02.008     Document Type: Article

References (42)

1. Aarestrup F.M., Hasman H., Jensen L.B., Moreno M., Herrero I.A., Dominguez L., Finn M., and Franklin A. Antimicrobial resistance among enterococci from pigs in three European countries. Applied and Environmental Microbiology 68 (2002) 4127-4129
2. Bean D.C., and Klena J.D. Prevalence of erm(A) and mef(B) erythromycin resistance determinants in isolates of Streptococcus pneumoniae from New Zealand. The Journal of Antimicrobial Chemotherapy 50 (2002) 597-599
3. Brown S.D., and Farrell D.J. Antibacterial susceptibility among Streptococcus pneumoniae isolated from paediatric and adult patients as part of the PROTEKT US study in 2001-2002. The Journal of Antimicrobial Chemotherapy 54 Suppl. 1 (2004) i23-i29
4. Cochetti I., Vecchi M., Mingoia M., Tili E., Catania M.R., Manzin A., Varaldo P.E., and Montanari M.P. Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I). Antimicrobial Agents and Chemotherapy 49 (2005) 4999-5006
5. Desjardins M., Delgaty K.L., Ramotar K., Seetaram C., and Toye B. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. Journal of Clinical Microbiology 42 (2004) 5620-5623
6. DiPersio L.P., DiPersio J.R., Beach J.A., and DeFine L.A. Rise of Streptococcus pneumoniae isolates containing both erm(B) and mef(E) genes from an adult tertiary care community hospital system. Diagnostic Microbiology and Infectious Disease 55 (2006) 327-331
7. Farrell D.J., and Jenkins S.G. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002. The Journal of Antimicrobial Chemotherapy 54 Suppl. 1 (2004) i17-i22
8. Farrell D.J., Jenkins S.G., Brown S.D., Patel M., Lavin B.S., and Klugman K.P. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerging Infectious Diseases 11 (2005) 851-858
9. Felmingham D., Reinert R.R., Hirakata Y., and Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. The Journal of Antimicrobial Chemotherapy 50 Suppl. S1 (2002) 25-37
10. Hiramatsu K., Ohama M., Mijajima Y., Kishi K., Mizunoe S., Tokimatsu I., Nagai H., Kadota J., Saikawa T., and Nasu M. Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae. International Journal of Antimicrobial Agents 24 (2004) 125-129
11. Hoban D.J., Wierzbowski A.K., Nichol K., and Zhanel G.G. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides. Antimicrobial Agents and Chemotherapy 45 (2001) 2147-2150
12. Klugman K.P., Capper T., Widdowson C.A., Koornhof H.J., and Moser W. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. The Journal of Antimicrobial Chemotherapy 42 (1998) 729-734
13. Ko W.C., Yan J.J., Lee N.Y., Wu H.M., and Wu J.J. Polyclonal spread of erythromycin-resistant Streptococcus agalactiae in southern Taiwan. Microbial Drug Resistance 10 (2004) 306-312
14. Loch I.M., Glenn K., and Zadoks R.N. Macrolide and lincosamide resistance genes of environmental streptococci from bovine milk. Veterinary Microbiology 111 (2005) 133-138
15. Luk W.K., Wong S.S.Y., Yuen K.Y., Ho P.L., Woo P.C.Y., Lee R.A., and Chau P.Y. Inpatient emergencies encountered by an infectious disease consultative service. Clinical Infectious Diseases (an official publication of the Infectious Diseases Society of America) 26 (1998) 695-701
16. Marie J., Morvan H., Berthelot-Herault F., Sanders P., Kempf I., Gautier-Bouchardon A.V., Jouy E., and Kobisch M. Antimicrobial susceptibility of Streptococcus suis isolated from swine in France and from humans in different countries between 1996 and 2000. The Journal of Antimicrobial Chemotherapy 50 (2002) 201-209
17. Materl A., Baele M., Devriese L.A., Goossens H., Wisselink H.J., Decostere A., and Haesebrouck F. Prevalence and mechanism of resistance against macrolides and lincosamides in Streptococcus suis isolates. Veterinary Microbiology 83 (2001) 287-297
18. McGee L., Klugman K.P., Wasas A., Capper T., and Brink A. Serotype 19F multiresistant pneumococcal clone harboring two erythromycin resistance determinants [erm(B) and mef(A)] in South Africa. Antimicrobial Agents and Chemotherapy 45 (2001) 1595-1598
19. Montanari M.P., Cochetti I., Mingoia M., and Varaldo P.E. Phenotypic and molecular characterization of tetracycline- and erythromycin- resistant strains of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 47 (2003) 2236-2241
20. Murray B.E. Diversity among multidrug-resistant enterococci. Emerging Infectious Diseases 4 (1998) 37-47
21. Murray P.R., Baro E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.H. Manual of Clinical Microbiology. eighth ed. (2003), American Society for Microbiology, Washington, DC
22. National Committee for Clinical Laboratory Standards, 2004. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Test for Bacteria Isolated from Animals: Approved Standard, second ed., NCCLS document M31-A2, Wayne, USA.
23. Nishijima T., Saito Y., Aoki A., Toriya M., Toyonaga Y., and Fujii R. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics. The Journal of Antimicrobial Chemotherapy 43 (1999) 637-643
24. Novotna G., and Janata J. A new evolutionary variant of the Streptogramin A resistance protein, Vga(A)LC, from Staphylococcus haemolyticus with shifted substrate specificity towards lincosamides. Antimicrobial Agents and Chemotherapy 50 (2006) 4070-4076
25. Pan T.M., Lin S.S., Yu Y.L., and Horng C.B. Serotype distribution and antimicrobial susceptibility of group A streptococci (Streptococcus pyogenes) isolated in Taiwan. Chinese Journal of Microbiology and Immunology 29 (1996) 153-161
26. Pottumarthy S., Fritsche T.R., Sader H.S., Stilwell M.G., and Jones R.N. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents. International Journal of Antimicrobial Agents 25 (2005) 282-289
27. Reinert R.R., Franken C., van der Linden M., Cil M.Y., and Al-Lahham A. Molecular characterization of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003. International Journal of Antimicrobial Agents 24 (2004) 43-47
28. Reinert R.R., Ringelstein A., van der Linden M., Cil M.Y., Al-Lahham A., and Schmitz F.J. Molecular epidemiology of macrolide- resistant Streptococcus pneumoniae isolates in Europe. Journal of Clinical Microbiology 43 (2005) 1294-1300
29. Song J.H., Chang H.H., Suh J.Y., Ko K.S., Jung S.I., Oh W.S., Peck K.R., Lee N.Y., Yang Y., Chongthaleong A., Aswapokee N., Chiu C.H., Lalitha M.K., Perera J., Yee T.T., Kumararasinghe G., Jamal F., Kamarulazaman A., Parasakthi N., Van P.H., So T., Ng T.K., and ANSORP Study Group. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). The Journal of Antimicrobial Chemotherapy 53 (2004) 457-463
30. Sutcliffe J., Tait-Kamradt A., and Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrobial Agents and Chemotherapy 40 (1996) 1817-1824
31. Tenover F.C. Studies of antimicrobial resistance genes using DNA probes. Antimicrobial Agents and Chemotherapy 29 (1988) 721-725
32. Tenover F.C., Popovic T., and Olsvik O. Using molecular methods to detect antimicrobial resistance genes. Clinical Microbiology Newsletter 15 (1993) 177-184
33. Tiemei Z., Xiangqun F., and Youning L. Resistance phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shenyang, China. Antimicrobial Agents and Chemotherapy 48 (2004) 4040-4041
34. Tillotson L.E., Jenssen W.D., Moon-McDermott L., and Dubin D.T. Characterization of a novel insertion of the macrolides-lincosamides-streptogramin B resistance transposon Tn554 in methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy 33 (1989) 541-550
35. Toltzis P., Dul M., O'riordan M.A., Jacobs M.R., and Blumer J. Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city. The Pediatric Infectious Disease Journal 25 (2006) 19-24
36. Uh Y., Kim H.Y., Jang I.H., Hwang G.Y., and Yoon K.J. Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae. Yonsei Medical Journal 46 (2005) 480-483
37. Waites K.B., Jones K.E., Kim K.H., Moser S.A., Johnson C.N., Hollingshead S.K., Kang E.S., Hong K.S., and Benjamin Jr. W.H. Dissemination of macrolide-resistant Streptococcus pneumoniae isolates containing both erm(B) and mef(A) in South Korea. Journal of Clinical Microbiology 41 (2003) 5787-5791
38. Weiss K., Guilbault C., Cortes L., Restieri C., Low D.E., and the EQUERE project. Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin. The Journal of Antimicrobial Chemotherapy 50 (2002) 403-406
39. Wierzbowski A.K., Swedlo D., Boyd D., Mulvey M., Nichol K.A., Hoban D.J., and Zhanel G.G. Molecular epidemiology and prevalence of macrolide efflux genes mef(A) and mef(E) in Streptococcus pneumoniae obtained in Canada from 1997 to 2002. Antimicrobial Agents and Chemotherapy 49 (2005) 1257-1261
40. Wu, Z.B., 2003. Studies on Gram-positive Streptococcus-like bacteria infections in fish. MD thesis, National Ping Tung University of Science and Technology, Taiwan.
41. Yan J.J., Wu H.M., Huang A.H., Fu H.M., Lee C.T., and Wu J.J. Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A Streptococci in Southern Taiwan. Journal of Clinical Microbiology 38 (2000) 2475-2479
42. Yang H., Yang Y.H., Nielsen E., Yu S.J., Yuan L., Wang Y.H., and Shen X.Z. Distribution of resistance genes ermB, mefA, tetM and the integrase gene intTn of Tn1545 in Streptococcus pneumoniae. Chinese Journal of Microbiology and Immunology 25 (2005) 677-682